|
1.
|
Hultgren R, Granath F and Swedenborg J:
Different disease profiles for women and men with abdominal aortic
aneurysms. Eur J Vasc Endovasc Surg. 33:556–560. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Michel JB, Martin-Ventura JL, Egido J, et
al: Novel aspects of the pathogenesis of aneurysms of the abdominal
aorta in humans. Cardiovasc Res. 90:18–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Sakalihasan N, Limet R and Defawe OD:
Abdominal aortic aneurysm. Lancet. 365:1577–1589. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Pajič T: Factor V Leiden and FII 20210
testing in thromboembolic disorders. Clin Chem Lab Med. 48(Suppl
1): 79–87. 2010.PubMed/NCBI
|
|
5.
|
Bos MHA and Camire RM: Blood coagulation
factors V and VIII: molecular mechanisms of procofactor activation.
J Coagul Disord. 2:19–27. 2010.PubMed/NCBI
|
|
6.
|
Vos HL: Inherited defects of coagulation
factor V: the thrombotic side. J Thromb Haemost. 4:35–40. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Griffin JH, Evatt B, Wideman C and
Fernandez JA: Anticoagulant protein C pathway defective in majority
of thrombophilic patients. Blood. 82:1989–1993. 1993.PubMed/NCBI
|
|
8.
|
Koster T, Rosendaal FR, de Ronde H, Briet
E, Vandenbroucke JP and Bertina RM: Venous thrombosis due to poor
anticoagulant response to activated protein C: Leiden Thrombophilia
Study. Lancet. 342:1503–1506. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bauer KA: Activation of the factor
VII-tissue factor pathway. Thromb Haemost. 78:108–111.
1997.PubMed/NCBI
|
|
10.
|
Humphries S, Temple A, Lane A, Green F,
Cooper J and Miller G: Low plasma levels of factor VIIc and antigen
are more strongly associated with the 10 base pair promoter (−323)
insertion than the glutamine 353 variant. Thromb Haemost.
75:567–572. 1996.PubMed/NCBI
|
|
11.
|
Shimokata K, Kondo T, Ohno M, et al:
Effects of coagulation Factor VII polymorphisms on the coronary
artery disease in Japanese: Factor VII polymorphism and coronary
disease. Thromb Res. 105:493–498. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Marino MW, Fuller GM and Elder FF:
Chromosomal localization of human and rat A alpha, B beta, and
gamma fibrinogen genes by in situ hybridization. Cytogenet Cell
Genet. 42:36–41. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lee SH, Kim MK, Park MS, Choi SM, Kim JT,
Kim BC and Cho KH: Beta-fibrinogen gene −455 G/A polymorphism in
Korean ischemic stroke patients. J Clin Neurol. 4:17–22. 2008.
|
|
14.
|
Pongrácz E, Andrikovics H, Csornai M,
Bernát IS and Nagy Z: Contribution of the −455G/A polymorphism at
beta-fibrinogen gene and of the Leiden mutation to hemorheological
parameters in ischemic stroke patients. Clin Hemorheol Microcirc.
35:75–82. 2006.
|
|
15.
|
Renner W, Cichocki L, Forjanics A, Köppel
H, Gasser R and Pilger E: G-455A polymorphism of the fibrinogen
beta gene and deep vein thrombosis. Eur J Clin Invest. 32:755–758.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Voetsch B and Loscalzo J: Genetic
determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol.
24:216–229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Lee AJ, Fowkes FG, Lowe GD and Rumley A:
Haemostatic factors, atherosclerosis and risk of abdominal aortic
aneurysm. Blood Coagul Fibrinolysis. 7:695–701. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Takagi H, Manabe H, Kawai N, Goto S and
Umemoto T: Plasma fibrinogen and D-dimer concentrations are
associated with the presence of abdominal aortic aneurysm: a
systematic review and meta-analysis. Eur J Vasc Endovasc Surg.
38:273–277. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lee AJ, Fowkes FG, Lowe GD, Connor JM and
Rumley A: Fibrinogen, factor VII and PAI-1 genotypes and the risk
of coronary and peripheral atherosclerosis. Edinburgh Artery Study
Thromb Haemost. 81:553–560. 1999.PubMed/NCBI
|
|
20.
|
de Maat MP, Kastelein JJ, Jukema JW, et
al: −455G/A polymorphism of the beta-fibrinogen gene is associated
with the progression of coronary atherosclerosis in symptomatic
men: proposed role for an acute-phase reaction pattern of
fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol.
18:265–271. 1998.
|
|
21.
|
Martiskainen M, Pohjasvaara T, Mikkelsson
J, et al: Fibrinogen gene promoter −455 A allele as a risk factor
for lacunar stroke. Stroke. 34:886–891. 2003.
|
|
22.
|
Bozdemir V, Kirimli O, Akdeniz B, et al:
The association of beta-fibrinogen 455 G/A gene polymorphism with
left atrial thrombus and severe spontaneous echo contrast in atrial
fibrillation. Anadolu Kardiyol Derg. 10:209–215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
van ‘t Hooft FM, von Bahr SJ, Silveira A,
Iliadou A, Eriksson P and Hamsten A: Two common, functional
polymorphisms in the promoter region of the beta-fibrinogen gene
contribute to regulation of plasma fibrinogen concentration.
Arterioscler Thromb Vasc Biol. 19:3063–3070. 1999.PubMed/NCBI
|
|
24.
|
Leander K, Wiman B, Hallqvist J, Falk G
and De Faire U: The G-455A polymorphism of the fibrinogen
Bbeta-gene relates to plasma fibrinogen in male cases, but does not
interact with environmental factors in causing myocardial
infarction in either men or women. J Intern Med. 252:332–341. 2002.
View Article : Google Scholar
|
|
25.
|
Iacoviello L, Vischetti M, Zito F and
Benedetta Donati M: Genes encoding fibrinogen and cardiovascular
risk. Hypertension. 38:1199–1203. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Green D, Foiles N, Chan C, Schreiner PJ
and Liu K: Elevated fibrinogen levels and subsequent subclinical
atherosclerosis: the CARDIA Study. Atherosclerosis. 202:623–331.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Rallidis LS, Gialeraki A, Fountoulaki K,
et al: G-455A polymorphism of beta-fibrinogen gene and the risk of
premature myocardial infarction in Greece. Thromb Res. 125:34–37.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Brown ET and Fuller GM: Detection of a
complex that associates with the Bβ fibrinogen G-455- A
polymorphism. Blood. 92:3286–3293. 1998.
|
|
29.
|
Singh K, Bønaa KH, Jacobsen BK, Bjørk L
and Solberg S: Prevalence of and risk factors for abdominal aortic
aneurysms in a population-based study: The Tromsø Study. Am J
Epidemiol. 154:236–244. 2001.PubMed/NCBI
|
|
30.
|
Al-Barjas HS, Ariëns R, Grant P and Scott
JA: Raised plasma fibrinogen concentration in patients with
abdominal aortic aneurysm. Angiology. 57:607–614. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Fowkes FG, Anandan CL, Lee AJ, et al:
Reduced lung function in patients with abdominal aortic aneurysm is
associated with activation of inflammation and hemostasis, not
smoking or cardiovascular disease. J Vasc Surg. 43:474–480. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Spring S, van der Loo B, Krieger E,
Amann-Vesti BR, Rousson V and Koppensteiner R: Decreased wall shear
stress in the common carotid artery of patients with peripheral
arterial disease or abdominal aortic aneurysm: relation to blood
rheology, vascular risk factors, and intima-media thickness. J Vasc
Surg. 43:56–63. 2006. View Article : Google Scholar
|
|
33.
|
Sofi F, Marcucci R, Giusti B, et al: High
levels of homocysteine, lipoprotein (a) and plasminogen activator
inhibitor-1 are present in patients with abdominal aortic aneurysm.
Thromb Haemost. 94:1094–1098. 2005.PubMed/NCBI
|
|
34.
|
Ioannou HV, Mitsis M, Eleftheriou A, et
al: The prevalence of factor V Leiden as a risk factor for venous
thromboembolism in the population of North-Western Greece. Int
Angiol. 19:314–318. 2000.PubMed/NCBI
|
|
35.
|
Juul K, Tybjaerg-Hansen A, Schnohr P and
Nordestgaard BG: Factor V Leiden and the risk for venous
thromboembolism in the adult Danish population. Ann Intern Med.
140:330–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Sofi F, Lar B, Rogolino A, et al:
Thrombophilic risk factors for symptomatic peripheral arterial
disease. J Vasc Surg. 41:255–260. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Reny JL, Alhenc-Gelas M, Fontana P, et al:
The factor II G20210A gene polymorphism, but not factor V
Arg506Gln, is associated with peripheral arterial disease: results
of a case-control study. J Thromb Haemost. 2:1334–1340. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Renner W, Köppel H, Brodmann M, et al:
Factor II G20210A and factor V G1691A gene mutations and peripheral
arterial occlusive disease. Thromb Haemost. 83:20–22.
2000.PubMed/NCBI
|
|
39.
|
März W, Seydewitz H, Winkelmann B, Chen M,
Nauck M and Witt I: Mutation in coagulation factor V associated
with resistance to activated protein C in patients with coronary
artery disease. Lancet. 345:526–527. 1995.PubMed/NCBI
|
|
40.
|
Rosendaal FR, Siscovick DS, Schwartz SM,
et al: Factor V Leiden (resistance to activated protein C)
increases the risk of myocardial infarction in young women. Blood.
89:2817–2821. 1997.PubMed/NCBI
|
|
41.
|
Liu Y, Hengen CK, Saha N, Hong S and Low
PS: Genotype associations of factor VII gene with plasma factor VII
coagulant activity and antigen levels in healthy Chinese. Blood
Coagul Fibrinolysis. 13:217–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Sacchi E, Tagliabue L, Scoglio R,
Baroncini C, Coppola R, Bernardi F and Mannucci PM: Plasma factor
VII levels are influenced by a polymorphism in the promoter region
of the FVII gene. Blood Coagul Fibrinolysis. 7:114–117. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Mtiraoui N, Aboud N, Bouraoui H, et al:
Reduction in coagulation factor VII plasma levels by R353Q but not
the −323P0/10 promoter polymorphism in healthy Tunisians. Am J
Hematol. 79:11–16. 2005.
|
